4Boente MP,Chi DS,Hoskins WJ.The role of surgery in the management of ovarian cancer:primary and interval cytoreductive surgery[J].Semin Oncol,1998,25(3):326～334
5Hoskins WJ,McGuire WP,Brady MF,et al.The effect of diameter of largest residual disease on survival after primary cytoreducfive surgery in patients with suboptimal residual epithelial ovarian carcinoma[J].Am J Obstet Gynecol,1994,170(4):974～979
8Griffilhs CT, Fuller AF. Intensive surgical and chemotherapcutic management of adyanced ovarian cancer. Chn Surg North Am, 1978,58:131-142.
9Hegazy MA, Hegazi RA, Elshafei MA, et al. Neoad juoant chemotherapy versus primary surgery in advanced ovarian carcinoma. World J Surg Oncol, 2005,3 : 57-64.
10Loizzi V, Connio G, Resta L, et al. Neoadjuvant chemotherapy in advanced ovarian cancer a case control study. Int J Gynecol Cancer,2005,15 : 217-223.
